The long term goal of this project is to improve our understanding of molecular mechanisms of drug resistance and drug action in Mycobacterium tuberculosis. Such knowledge will be useful for rapid detection of drug resistant M. tuberculosis and rational design of new antituberculous drugs. Drug resistant tuberculosis is on the increase recently and poses serious threat to the treatment of the disease. This project proposes to study the molecular basis of pyrazinamide resistance in M. tuberculosis.
the specific aims of the project are: 1) To determine how acid pH potentiates pyrazinamide activity; 2) To characterize mutations in the pyrazinamidase gene and assess the role of these mutations in pyrazinamide resistance by transformation studies; 3) To develop a PCR-based test for rapid detection of pyrazinamide resistance in clinical isolates of M. tuberculosis. The health relatedness of this project lies in the possible development of a rapid test for direct detection of pyrazinamide resistance in clinical isolates of M. tuberculosis and also in the design of new antituberculous drugs based on the understanding of the drug action. Two hypotheses about the role of acid pH in potentiating pyrazinamide activity will be tested in Specific Aim 1. The first hypothesis that acid pH may enhance the uptake or transport of pyrazinamide in M. tuberculosis will be tested by monitoring the derivative of radioactive 14C-pyrazinamide by thin layer chromatography (TLC). the second hypothesis that acid pH may activate the pyrazinamidase gene or the enzyme itself will be tested by using reporter gene constructs and in vitro enzyme assays. Potential mutations in the pyrazinamidase gene among pyrazinamide-resistant M. tuberculosis strains will be analyzed by PCR sequencing. The role of the mutations in the pyrazinamidase gene will be assessed by transformation of resistant strains with a functional pyrazinamidase gene. Furthermore, a rapid test will be developed for detection of pyrazinamide resistance in M. tuberculosis by PCR-SSCP. Such a rapid DNA-based test is particularly important in view of the recent increase of drug resistant tuberculosis and the difficulty of current pyrazinamide susceptibility testing.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI040584-03
Application #
2887337
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Laughon, Barbara E
Project Start
1997-09-01
Project End
2000-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Microbiology/Immun/Virology
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Zhang, Ying; Permar, Sallie; Sun, Zhonghe (2002) Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J Med Microbiol 51:42-9
Schaller, Alain; Sun, Zhonghe; Yang, Yongping et al. (2002) Salicylate reduces susceptibility of Mycobacterium tuberculosis to multiple antituberculosis drugs. Antimicrob Agents Chemother 46:2636-9
Sun, Z; Cheng, S J; Zhang, H et al. (2001) Salicylate uniquely induces a 27-kDa protein in tubercle bacillus. FEMS Microbiol Lett 203:211-6
Zhang, Y; Yang, Y; Woods, A et al. (2001) Resuscitation of dormant Mycobacterium tuberculosis by phospholipids or specific peptides. Biochem Biophys Res Commun 284:542-7
Guo, M; Sun, Z; Zhang, Y (2000) Mycobacterium smegmatis has two pyrazinamidase enzymes, PncA and pzaA. J Bacteriol 182:3881-4
Cheng, S J; Thibert, L; Sanchez, T et al. (2000) pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother 44:528-32
Zhang, Y; Scorpio, A; Nikaido, H et al. (1999) Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Bacteriol 181:2044-9
Sun, Z; Zhang, Y (1999) Spent culture supernatant of Mycobacterium tuberculosis H37Ra improves viability of aged cultures of this strain and allows small inocula to initiate growth. J Bacteriol 181:7626-8
Sun, Z; Zhang, Y (1999) Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. Antimicrob Agents Chemother 43:537-42